BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.
THIS volume is a collection of bulletins published monthly by the Technical Instruction Committee of the Essex County Council, as an aid to the teaching of biology. It contains information bearing ...
BridgeBio also intends to use up to $82.5 million of cash on hand to repurchase shares of its common stock from certain note purchasers in privately negotiated transactions concurrent with the pricing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results